Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Is Opportunity To Level Retail And PBM Drug Prices, NACDS Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The central role of retail pharmacies in implementing the new drug benefit could give the industry leverage to obtain drug prices similar to those paid by pharmacy benefit managers. The National Association of Chain Drug Stores will begin working with PhRMA on the issue "in the next week or two," Chairman Civello says.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062303

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel